Risultati della ricerca - Rodger D. MacArthur
- Mostra 1 - 11 risultati su 11
-
1
-
2
Reviews Of Anti‐infective Agents: Maraviroc: The First of a New Class of Antiretroviral Agents di Rodger D. MacArthur, Richard M. Novak
Pubblicazione 2008Revisão -
3
-
4
-
5
Poor Initial CD4+ Recovery With Antiretroviral Therapy Prolongs Immune Depletion and Increases Risk for AIDS and Non-AIDS Diseases di Jason V. Baker, Grace Peng, Joshua Rapkin, David Krason, Cavan Reilly, Winston Cavert, Donald I. Abrams, Rodger D. MacArthur, Keith Henry, James D. Neaton
Pubblicazione 2008Artigo -
6
-
7
Treatment with Lamivudine, Zidovudine, or Both in HIV-Positive Patients with 200 to 500 CD4+ Cells per Cubic Millimeter di Joseph J. Eron, Sharon L. Benoit, Joseph G. Jemsek, Rodger D. MacArthur, Jorge Santana, Joseph Quinn, Daniel R. Kuritzkes, Mary Ann Fallon, Marc Rubin
Pubblicazione 1995Artigo -
8
Antiretroviral medication adherence and class-specific resistance in a large prospective clinical trial di Edward M. Gardner, Katherine Huppler Hullsiek, Edward E. Telzak, Shweta Sharma, Grace Peng, William J. Burman, Rodger D. MacArthur, Margaret A. Chesney, Gerald Friedland, Sharon Mannheimer
Pubblicazione 2010Artigo -
9
Differential adherence to combination antiretroviral therapy is associated with virological failure with resistance di Edward M. Gardner, Shweta Sharma, Grace Peng, Katherine Huppler Hullsiek, William J. Burman, Rodger D. MacArthur, Margaret A. Chesney, Edward E. Telzak, Gerald Friedland, Sharon Mannheimer
Pubblicazione 2008Artigo -
10
Prevalence of Antiretroviral Drug Resistance Mutations in Chronically HIV-Infected, Treatment-Naive Patients: Implications for Routine Resistance Screening before Initiation of Ant... di Richard M. Novak, L. Chen, Rodger D. MacArthur, John D. Baxter, Katherine Huppler Hullsiek, Grace Peng, Ying Xiang, Christopher Henely, Barry Schmetter, J. Uy, Mary van den Berg-Wolf, Michael J. Kozal
Pubblicazione 2005Artigo -
11
Low-Abundance Drug-Resistant Viral Variants in Chronically HIV-Infected, Antiretroviral Treatment–Naive Patients Significantly Impact Treatment Outcomes di Birgitte B. Simen, Jan Fredrik Simons, Katherine Huppler Hullsiek, Richard M. Novak, Rodger D. MacArthur, John D. Baxter, Chunli Huang, Christine K Lubeski, Gregory S. Turenchalk, Michael Braverman, Brian Desany, Jonathan M. Rothberg, Michael D. Miller, Michael J. Kozal
Pubblicazione 2009Artigo
Strumenti per la ricerca:
Soggetti correlati
Medicine
Internal medicine
Immunology
Human immunodeficiency virus (HIV)
Viral load
Antiretroviral therapy
Virology
Virus
Confidence interval
Viral disease
Biology
Genetics
Hazard ratio
Proportional hazards model
Reverse-transcriptase inhibitor
Sida
Adverse effect
Drug
Drug resistance
Gene
Hepatitis B virus
Immune system
Lamivudine
Pharmacology
Polymerase chain reaction
Resistance mutation
Reverse transcriptase
Zidovudine
Bacteria
Bone mass